Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine liposome injection versus ropivacaine for regional nerve block after breast cancer surgery
ChiCTR2400082230Phase 2Not yet recruiting
- Sponsor
- Henan Cancer Hospital
- Start
- Mar 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in postoperative pain comparing Ropivacaine injection group with Bupivacaine liposome injection group (2 arms). Primary endpoint: Pain intensity score. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
bupivacaineropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400082230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400082230.